Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-05-18 @ 7:02 PM
Study NCT ID:
NCT06176560
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-19
First Post:
2023-12-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.
Sponsor:
Faes Farma, S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CGRA-0121/ES
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None